Cancer Research Donn Young  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiyama, N.
Right arrow Articles by Kopecek, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiyama, N.
Right arrow Articles by Kopecek, J.
[Cancer Research 63, 7876-7882, November 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Free and N-(2-Hydroxypropyl)methacrylamide Copolymer-bound Geldanamycin Derivative Induce Different Stress Responses in A2780 Human Ovarian Carcinoma Cells

Nobuhiro Nishiyama, Aparna Nori, Alexander Malugin, Yuji Kasuya, Pavla Kopecková and Jindrich Kopecek

Department of Pharmaceutics and Pharmaceutical Chemistry/Center for Controlled Chemical Delivery (CCCD), University of Utah, Salt Lake City, Utah

The effects of geldanamycin (GA), 17-(3-aminopropylamino)-17-demethoxygeldanamycin (AP-GA), and N-(2-hydroxypropyl)methacrylamide copolymer-AP-GA conjugate [P(AP-GA)] on A2780 human ovarian carcinoma cells at an equitoxic dose (2x IC50) were compared by the gene expression array analysis. All treatments resulted in similar gene expression profiles up to 12 h (e.g., down-regulation of CDK4 and up-regulation of APAF-1), although P(AP-GA)-treated cells showed delayed gene expression because of time-dependent internalization of the conjugate and intracellular drug release from P(AP-GA). However, AP-GA-treated cells showed elevated expression of HSP70 and HSP27 after 6 h compared with that observed by GA and P(AP-GA) treatments. Depletion of C-Raf, an HSP90 client protein, was observed in all treatments up to 12 h. Confocal microscopy using mesochlorin e6 as a model drug revealed that drug release caused by the lysosomal cleavage of glycylphenylalanylleucylglycine oligopeptide spacer, used as GA derivative copolymer attachment/release point, was moderately fast. These results suggested that AP-GA treatment may activate stress-response pathways, whereas P(AP-GA) treatment may suppress them and trigger signaling pathways essential to cell growth arrest and death by inducing an HSP90-active factor. Although GA and P(AP-GA) treatments induced a time-dependent increase in HSP70 and HSP27 protein expression (detected by Western blotting analysis), AP-GA treatment resulted in more rapid and more intense expression of both proteins. Our results suggest that conjugation of AP-GA to N-(2-hydroxypropyl)methacrylamide copolymer may be able to modulate the cell stress responses induced by AP-GA because of differences in its internalization mechanism, subcellular localization, and intracellular concentration gradients.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
M. R. Dreher and A. Chilkoti
Toward a Systems Engineering Approach to Cancer Drug Delivery
J Natl Cancer Inst, July 4, 2007; 99(13): 983 - 985.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Schluep, J. Hwang, J. Cheng, J. D. Heidel, D. W. Bartlett, B. Hollister, and M. E. Davis
Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models
Clin. Cancer Res., March 1, 2006; 12(5): 1606 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R Duncan, M J Vicent, F Greco, and R I Nicholson
Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
Endocr. Relat. Cancer, July 1, 2005; 12(Supplement_1): S189 - S199.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Schulz, E. Anter, M.-H. Zou, and J. F. Keaney Jr
Estradiol-Mediated Endothelial Nitric Oxide Synthase Association With Heat Shock Protein 90 Requires Adenosine Monophosphate-Dependent Protein Kinase
Circulation, June 28, 2005; 111(25): 3473 - 3480.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Peng, X. Guo, S. C. Borkan, A. Bharti, Y. Kuramochi, S. Calderwood, and D. B. Sawyer
Heat Shock Protein 90 Stabilization of ErbB2 Expression Is Disrupted by ATP Depletion in Myocytes
J. Biol. Chem., April 1, 2005; 280(13): 13148 - 13152.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.